US Patent 7611728 Osmotic delivery of therapeutic compounds by solubility enhancement
Patent 7611728 was granted and assigned to Supernus Pharmaceuticals, Inc. on November, 2009 by the United States Patent and Trademark Office.
All edits
Edits on 3 Jul, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 3 Jan, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 17 Sep, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Argaw Kidane0
Jones W. Bryan, Jr.0
Padmanabh P. Bhatt0
Shimul K. Ray0
Edits on 16 Sep, 2023
Golden AI
Edits made to:
Article (+521 characters)
Article
Patent abstract
The present invention is directed to the oral osmotic delivery of therapeutic compounds that have limited solubility in an aqueous environment due to inherent hydrophobicity or to saturation limitations in the core of the osmotic system. The present invention is suitable for the osmotic delivery of glipizide and other hydrophobic drugs, but runs the spectrum to other therapeutic agents with higher aqueous solubilities, yet having a solubility limitation in an osmotic dosage unit due to high drug load.
Edits on 13 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07611728 Osmotic delivery of therapeutic compounds by solubility enhancement US Patent 7611728 Osmotic delivery of therapeutic compounds by solubility enhancement
Infobox
Patent Number
076117280
Patent Number
76117280
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 27 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
076117280
Date of Patent
November 3, 2009
0Patent Application Number
106557250
Date Filed
September 5, 2003
0Official Website
Patent Primary Examiner
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 3 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07611728 Osmotic delivery of therapeutic compounds by solubility enhancement
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07611728
Date of patent
November 3, 2009
Patent application number
10655725
Date Filed
September 5, 2003
Patent primary examiner
Find more entities like US Patent 7611728 Osmotic delivery of therapeutic compounds by solubility enhancement
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
